MRK
Merck & Co., Inc.
NYQ
$115.65
+0.48
(+0.42%)
Neutral · -0.08σ
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$285.6B
P/E ttm
32.6
Fwd P/E
12.1
Beta
0.20
Day range
$115.65
52w range
$96.06 – $125.14
Avg vol
9.5M
RSI(2)
22.6
ROE
18.9%
Net mgn
13.6%
FCF mgn
21.4%
Debt/Eq
1.07
Div yld
295.00%
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earn
2026-08-04
Matrix setup grades
Long
—
score 15 · tech 15 / 80 · support 0 / 20
above KC1 lower, -0.10 ATR from EMA21 · no notable pattern
- · RSI cushion turning up (50)
- · Aligned with weak uptrend
Short
—
score 9 · tech 9 / 80 · support 0 / 20
below KC1 upper, -0.10 ATR from EMA21 · no notable pattern
Options · swing
See more →
CALL
$115
2026-07-17
$4.88
PUT
$115
2026-07-17
$4.42
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-30
- EPS (act / est)
- -1.28 / -1.47
- Surprise
- +13.2%
- Next report
- 2026-08-04
About
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, B…